U.S. Charges in Generic-Drug Probe Said to Be Filed in 2016

U.S. Charges in Generic-Drug Probe Said to Be Filed in 2016


U.S. prosecutors are bearing down on generic pharmaceutical companies in a sweeping criminal investigation into suspected price collusion, a fresh challenge for an industry that's already reeling from public outrage over the spiraling costs of some medicines. The antitrust investigation by the Justice Department, begun about two years ago, now spans more than a dozen companies and about two dozen drugs, according to people familiar with the matter.



from Biotech News